MRNA vs UTHR
Moderna, Inc. · United Therapeutics Corporation
Relative return (rebased to 100)
Key stats
| Metric | MRNA | UTHR |
|---|---|---|
| Price | $226.30 | $540.03 |
| Market Cap | $90.35B | $23.16B |
| P/E | — | 17.35 |
| P/B | 13.36 | 3.62 |
| P/S | 46.47 | 7.28 |
| ROE | -41.7% | 20.9% |
| Net Margin | -145.2% | 41.9% |
| Gross Margin | — | 87.9% |
| Revenue Growth | -39.9% | 10.6% |
| Dividend Yield | — | — |
| EPS | -$7.07 | $31.12 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.